Celldex Therapeutics


Stock Update (NASDAQ:CLDX): Celldex Therapeutics, Inc. Appoints Richard Wright as Chief Commercial Officer

Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced the promotion of Richard Wright, Ph.D. to Senior Vice President …

Stock Update (NASDAQ:CLDX): Celldex Therapeutics, Inc. Reports First Quarter 2015 Results

Celldex Therapeutics, Inc. (NASDAQ:CLDX) reported business and financial highlights for the first quarter ended March …

Roth Capital Reiterates Buy On Celldex Therapeutics; Encouraged By The BTD Designation For Rintega

Celldex Therapeutics, Inc. (NASDAQ:CLDX) received another set of praises from analysts at Roth Capital, in …

Stock Update (NASDAQ:CLDX): Celldex Therapeutics Announces Proposed Public Offering of Common Stock

Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced that it is offering 7.25 million shares of its common …

Cowen & Co Shares Positive Outlook On Celldex Therapeutics Following FDA ‘Breakthrough’ Approval

Shares of Celldex Therapeutics (NASDAQ: CLDX) shot up about 17.5% in trading on February 23rd following the …

Stock Update (NASDAQ:CLDX): Celldex Reports Fourth Quarter and Year-End 2014 Results

Celldex Therapeutics, Inc. (Nasdaq:CLDX) reported business and financial highlights for the fourth quarter and year ended …